Qianni Cheng
Yale University(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Fibroblast Growth Factor Research, Fatty Acid Research and Health
Most-Cited Works
- → High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets(2013)100 cited
- → Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk(2017)98 cited
- → Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1 H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-l-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes(2008)73 cited
- → Targeted Inactivation of Kinesin-1 in Pancreatic β-Cells In Vivo Leads to Insulin Secretory Deficiency(2010)66 cited
- → An update on the islet renin–angiotensin system(2011)43 cited
- → Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets(2015)39 cited
- → Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states(2016)27 cited
- → Angiotensin II exerts glucose-dependent effects on Kvcurrents in mouse pancreatic β-cells via angiotensin II type 2 receptors(2009)27 cited
- → Hedgehog signaling in bone regulates whole-body energy metabolism through a bone–adipose endocrine relay mediated by PTHrP and adiponectin(2016)22 cited
- → A hypothalamic pathway for Augmentor α–controlled body weight regulation(2022)22 cited